IM Cannabis Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Toronto and glil yam, israel , april 9, 2024 /prnewswire/ -- im cannabis corp. (cse: imcc) (nasdaq: imcc) (the "company", "imcannabis", or "imc"), a leading medical cannabis company with operations in israel and germany, entered, through its subsidiary, a strategic distribution agreement with vessel brand inc, a subsidiary of flora growth corp. ("flora"), a global consumer-packaged goods leader and pharmaceutical distributor, headquartered in carlsbad, ca.    imc's brands are well known in the premium israeli cannabis market, facilitating the import and wholesale of premium medical cannabis through retail pharmacies, online platform, and distribution center.

Kelowna, bc, toronto, on and glil yam, israel / accesswire / april 4, 2024 / avant brands inc. (tsx:avnt)(otcqx:avtbf)(fra:1bu0) ("avant" or the "company"), a leading producer of innovative and award-winning cannabis products and im cannabis corp. (cse:imcc)(nasdaq:imcc) (the "company", "imcannabis", or "imc"), a leading medical cannabis company with operations in israel and germany, are pleased to announce the signing of an international trademark licensing agreement (the "licensing agreement") granting imc's german subsidiary, adjupharm gmbh ("adjupharm"), the exclusive right to launch avant's flagship brand, blk mkt™ brand in the german cannabis market. the licensing agreement constitutes a significant expansion of the relationship between the two industry-leading cannabis companies.

With the implementation of the anticipated medical cannabis regulatory reform, the israeli ministry of health removed many of the heavy regulations in the sector, making medical cannabis more accessible to new patients. toronto and glil yam, israel , april 1, 2024 /prnewswire/ -- im cannabis corp. (cse: imcc) (nasdaq: imcc) (the "company" or "imc"), a leading medical cannabis company with operations in israel and germany, welcomes the implementation of the medical cannabis regulatory reform in israel on april 1 st.

Toronto and glil yam, israel, march 28, 2024 /prnewswire/ -- im cannabis corp. (the "company" or "imc") (nasdaq: imcc) (cse: imcc), an international medical cannabis company, announced its financial and operational results for the year ended december 31, 2023, the highlights of which are included in this news release. all figures are reported in canadian dollars.

By rescheduling medical cannabis, from a narcotic to a regular prescription, the german medical cannabis market is expected to deliver strong growth, providing imc germany with a unique opportunity to further accelerate growth in 2024 after delivering 180% growth in 2023 toronto and glil yam, israel , march 25, 2024 /prnewswire/ -- im cannabis corp. (cse: imcc) (nasdaq: imcc) (the "company", "imcannabis", or "imc"), a leading medical cannabis company with operations in israel and germany, is welcoming the german government's final approval legalizing cannabis last friday, as well as the landmark medical cannabis act that has the potential to facilitate access for many new patients as of april 1 st...

The progress toward legalization of cannabis in the United States continues at a slow pace, but medical marijuana is now permitted in approximately 37 states. Germany recently became the latest country to legalize cannabis for personal use beginning in April, coinciding with the informal holiday of 4/20.

In the ever-evolving landscape of the US cannabis industry, marijuana stocks have been lighting up the market, with some experiencing triple-digit gains in the last month. Investors are keenly watching these volatile but potentially lucrative investments. The surge in interest comes as the industry sees an upward trajectory, buoyed by increasing legalization efforts and a growing acceptance of cannabis for both medical and recreational use. With the sector's projected expansion, savvy investors are diving into the market. However, it's crucial to approach these opportunities with a solid strategy, employing technical analysis and proper risk management to navigate the inherent risks.

The partnership's core objective is to grant IM Cannabis' (IMCC) subsidiary, Adjupharm GmbH, exclusive rights to introduce Avant's BLK MKT cannabis brand in Germany's medical cannabis market.

Marijuana stock investors are keeping their focus on the future. But why some may ask? With the cannabis sector being so volatile several things will need to take place for better trading. All of this will need to happen in the near to far future for stronger confidence regarding cannabis investing. This year we have seen a continuation of growth in the form of revenue and an increase in demand for more cannabis products.

IM Cannabis Corp. (IMCC) Q4 2023 Earnings Call Transcript

The cannabis industry over the last several years has seen tremendous growth. Many companies through ups and downs are seeing stronger sales. Recently companies have been reporting their earnings and the profits are high for most. This success has helped drive some much-needed moments into the stock market for certain marijuana stocks. Often when the news is impactful enough it can help how some cannabis stocks perform.

As the cannabis industry continues to flourish in the United States, investors are keenly watching the market for top-performing marijuana stocks. With the industry projected to reach a staggering $30 billion by 2025, the allure of double-digit gains before March is strong. Recent updates on federal legalization efforts have further invigorated the market. These developments promise to expand the industry's legal framework, potentially unlocking vast untapped markets. Investors are advised to employ technical analysis and proper risk management strategies. These tools are crucial for navigating the volatile cannabis sector. They help identify promising entry and exit points, maximizing returns while minimizing risks.

Even with the amount of progress the cannabis industry has seen investing in legal cannabis comes with big risks. As many know cannabis is now legal in more than 30 states in the US. This emerging industry has consistently generated over a billion in revenue. Not to mention it has employed many people who are looking for work. There seem to be more positives than negatives regarding legal cannabis so why is investing so risky?

This upcoming year marijuana stock investors await to see what will occur. There is a split between optimism and increased fears of what will go wrong. Many are still stuck in disbelief that there has been no advancement of any type of federal reform. You would think with over a billion dollars quarterly per legal state that federal reform would be a no-brainer. But it is not that simple however every time positive news on the matter is released the market begins to recover.

IM Cannabis Corp. (NASDAQ:IMCC ) Q3 2023 Results Conference Call November 13, 2023 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Executive Officer Itay Vago - Chief Financial Officer Conference Call Participants Scott Fortune - ROTH MKM Aaron Grey - Alliance Global Operator Good morning. And welcome to IM Cannabis' Third Quarter 2023 Earnings Conference Call.